Is a complete HEL/REG1V research report available?

Question

Accepted Answer

No complete published report is available for hel/REG1V (HEL/REG1V) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Market cap	325.1M
Revenue (ttm)	111M
Net income (ttm)	15.7M
EPS (ttm)	€0.59
Shares out	26.6M
P/E (trailing)	20.8x
P/E (forward)	14.3x
Dividend	€0.44 (3.60%)
Volume	0

Metric	Value
Country	Finland
Country code	FI
Employees	246
Employees Change	0%
Employees Change Percent	0
Enterprise value	EUR 314.5M
Exchange	Nasdaq Helsinki
Financial currency	EUR
First seen	2026-05-10
Industry	Medical Devices
Industry PE Fwd	32.09
Isin	FI0009010912
Last refreshed	2026-08-02
Market cap	EUR 325.1M
Price	EUR 12.22
Price currency	EUR
Rev Per Employee	451,402.44x
Sector	Healthcare
Sector PE	21.94
Sector PE Fwd	18.63
Sic	7373
Symbol	hel/REG1V
Website	https://www.reveniogroup.fi

Metric	Value
Earnings Yield	4.83%
EV Earnings	20.02x
EV/EBIT	6.03x
EV/EBITDA	5.56x
EV/FCF	15.09x
EV/Sales	2.83x
FCF yield	6.41%
Forward P/E	14.29x
P/B ratio	2.77x
P/E ratio	20.77x
P/S ratio	2.93x
PE Ratio10 Y	53.31x
PE Ratio3 Y	37.49x
PE Ratio5 Y	49.54x
PEG ratio	1.42x

Metric	Value
EBIT Margin	47.02%
EBITDA Margin	50.97%
FCF margin	18.76%
Gross margin	69.94%
Gross Profit	EUR 77.7M
Gross Profit Growth	2.68%
Gross Profit Growth Q	-1.58%
Gross Profit Growth3 Y	2.69%
Gross Profit Growth5 Y	10.53%
Net Income	EUR 15.7M
Net Income Growth	-17.73%
Net Income Growth Q	-40.48%
Net Income Growth Years	0%
Net Income Growth3 Y	-9.58%
Net Income Growth5 Y	0.85%
Pretax Margin	18.49%
Profit Margin	14.15%
Profit Per Employee	EUR 63,870
Profitable Quarters	EUR 45
Profitable Years	11
ROA	9.17
Roa5y	12.09
ROCE	41.46
ROE	13.7
Roe5y	20.52
ROIC	15.69
Roic5y	22.88

Metric	Value
Cagr10y	5.02%
Cagr15y	15.4%
Cagr1y	-54.51%
Cagr20y	16.02%
Cagr3y	-26.45%
Cagr5y	-28.44%
Div CAGR10	10.31%
Div CAGR3	5.57%
Div CAGR5	5.92%
EPS Growth	-17.71
EPS Growth Q	-41.4
EPS Growth Years	0
EPS Growth3 Y	-9.79
EPS Growth5 Y	0.69
FCF Growth	-8.68%
FCF Growth3 Y	-3.28%
FCF Growth5 Y	6.39%
OCF Growth	-7.67%
OCF Growth10 Y	18.05%
OCF Growth3 Y	-2.17%
OCF Growth5 Y	6.53%
Revenue Growth	4.44x
Revenue Growth Q	4.6x
Revenue Growth Quarters	10x
Revenue Growth Years	2x
Revenue Growth3 Y	3.47x
Revenue Growth5 Y	10.9x

HEL/REG1V (HEL/REG1V)

Coverage state: Market snapshot only — no published research

Generate the first HEL/REG1V analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · HEL/REG1V

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HEL/REG1V indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on HEL/REG1V

Frequently asked questions

Metric	Value
Asset Turnover	EUR 0.77
Assets	EUR 148.2M
Cash	EUR 21.4M
Current Assets	EUR 50.5M
Current Liabilities	EUR 22.3M
Debt	EUR 10.8M
Debt EBITDA	EUR 0.19
Debt Equity	EUR 0.09
Debt FCF	EUR 0.52
Equity	EUR 117.3M
Liabilities	EUR 30.9M
Long Term Assets	EUR 97.7M
Long Term Liabilities	EUR 8.6M
Net Cash	EUR 10.6M
Net Cash By Market Cap	EUR 3.26
Net Cash Growth	11.58%
Net Debt EBITDA	EUR -0.19
Net Debt Equity	EUR -0.09
Net Debt FCF	EUR -0.51
Tangible Book Value	EUR 30.3M
Tangible Book Value Per Share	EUR 1.12
WACC	8.63

Metric	Value
Current ratio	2.26
Inventory Turnover	3.19
Net Working Capital	EUR 12.5M
Quick ratio	1.76
Working Capital	EUR 28.2M
Working Capital Turnover	EUR 3.84

Metric	Value
Buyback Yield	0.02%
Dividend Growth Years	6%
Dividend per share	EUR 0.44
Dividend Years	19
Dividend Yield	3.6%
Last Dividend	EUR 0.4
Payout Ratio	67.71%

Metric	Value
10Y total return	63.11%
1Y total return	-54.49%
200-day SMA	18.16
3Y total return	-60.22%
50-day SMA	12.74
50-day SMA vs 200-day SMA	50under200
5Y total return	-81.23%
All Time High	72
All Time High Change	-83.03%
All Time High Date	2021-08-04
All Time Low	0.23
All Time Low Change	5,137.89%
All Time Low Date	2004-12-15
ATR	0.34
Beta	0.85
Beta1y	0.49
Beta2y	0.76
Ch YTD	-45.45
High	12.5
High52	27.25
High52 Date	2025-07-31
High52ch	-55.16%
Low	12.12
Low52	11.86
Low52 Date	2026-07-23
Low52ch	3.04%
Ma50ch	-4.04%
Price vs 200-day SMA	-32.72%
RSI	43.88
RSI Monthly	27.45
RSI Weekly	22.93
Sharpe ratio	-2.8x
Sortino ratio	-3.07
Total Return	3.62%
Tr YTD	-45.45
Tr15y	756.83%
Tr1m	0.16%
Tr1w	1.33%
Tr3m	-12.09%

Metric	Value
Analyst Count	3
Analyst Ratings	Buy
Operating Income	EUR 21.1M
Operating Income Growth	-22.57
Operating Income Growth Q	-65.15
Operating Income Growth3 Y	-11.31
Operating Income Growth5 Y	0.8
Operating margin	19.02
Price target	EUR 18
Price Target Change	EUR 47.3

Metric	Value
Float	24,635,415%
Net Borrowing	-6,021,000
Shares Insiders	5.99%
Shares Institutions	53.22%
Shares Out	26,605,266
Shares Qo Q	2.77%
Shares Yo Y	-0.02%

Metric	Value
Average Volume	40,915.25x
Bv Per Share	4.32
CAPEX	EUR -1.3M
Ch10y	43.82
Ch15y	532.2
Ch1m	0.16
Ch1w	1.33
Ch1y	-54.49
Ch20y	1,045.3
Ch3m	-12.09
Ch3y	-61.45
Ch5y	-82.13
Ch6m	-39.05
Change	-0.81%
Change From Open	-2.08
Close	12.32
Days Gap	1.3
Depreciation Amortization	2,877,000
Earnings Date	2026-09-08
EBIT	EUR 52.2M
EBITDA	EUR 56.6M
EPS	EUR 0.59
F Score	6
FCF	EUR 20.8M
FCF EV Yield	6.63x
FCF Per Share	EUR 0.78
Financing CF	-16,559,000
Fiscal Year End	December
Founded	2,001
Goodwill	63,400,000
Graham Number	7.55877
Graham Upside	-38.14
Income Tax	EUR 4.8M
Investing CF	-5,541,000
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Date	2018-03-21
Last Split Type	Forward
Lynch Fair Value	EUR 2.94
Lynch Upside	-75.93
Ma150	16.52
Ma150ch	-26.04%
Ma20	12.42
Ma20ch	-1.6%
Net CF	-745,000
Next Earnings Date	2026-09-08
Open	12.48
P FCF Ratio	15.6
P OCF Ratio	14.69
Payment Date	2025-04-23
Position In Range	26.32
Ppne	6,900,000
Price Date	2026-07-31
Price EBITDA	EUR 5.75
Ptbv Ratio	10.73
Relative Volume	1.89x
Revenue	111,045,000x
Tax By Revenue	4.34x
Tax Rate	23.46%
Tr20y	1,853%
Tr6m	-39.05%
Volume	0
Z Score	14.25